Vimta Labs Limited

VIMTALABS

INE579C01029

Biotechnology & Medical Research

Market Closed - Bombay S.E. Other stock markets 06:00:48 2024-05-16 am EDT			5-day change	1st Jan Change
498.8 ^INR	+1.71%		+3.56%	+23.51%

Mar. 02	Vimta Labs Limited Receives Grant in Aid for Upgrading of Food Testing Laboratory At Vimta Life Sciences Facility Plot No.5, Mn Science Technology Park, Genome Valley, Shameerpet, Hyderabad, Telangana	CI
Feb. 01	Transcript : Vimta Labs Limited, Q3 2024 Earnings Call, Feb 01, 2024

Vimta Labs Limited Announces the Appointment of Y Prameela Rani as Independent Director

August 25, 2018 at 07:34 am EDT

Vimta Labs Limited announced the appointment of Y Prameela Rani as Independent Director in its annual general meeting held on August 25, 2018.

Latest news about Vimta Labs Limited

Vimta Labs Limited Receives Grant in Aid for Upgrading of Food Testing Laboratory At Vimta Life Sciences Facility Plot No.5, Mn Science Technology Park, Genome Valley, Shameerpet, Hyderabad, Telangana	Mar. 02	CI
Transcript : Vimta Labs Limited, Q3 2024 Earnings Call, Feb 01, 2024	Feb. 01
Vimta Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 31	CI
Transcript : Vimta Labs Limited, Q2 2024 Earnings Call, Oct 30, 2023	23-10-30
Vimta Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-30	CI
Transcript : Vimta Labs Limited, Q1 2024 Earnings Call, Jul 31, 2023	23-07-31
Vimta Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-28	CI
CARE Gives A Rating to Vimta Labs' Long-term Bank Financing; Outlook Stable	23-07-12	MT
Vimta Labs Limited Declares Dividend for the Financial Year Ended March 31, 2023	23-06-28	CI
Transcript : Vimta Labs Limited, Q4 2023 Earnings Call, May 05, 2023	23-05-05
Vimta Labs Names New Executive Chairman	23-05-03	MT
Vimta Labs Limited Recommends Dividend for the Financial Year 2022-2023	23-05-03	CI
Vimta Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-03	CI
Transcript : Vimta Labs Limited, Q3 2023 Earnings Call, Jan 30, 2023	23-01-30
Vimta Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-27	CI
Brickwork Ratings Affirms A Rating on Vimta Labs' Bank Loans; Outlook Stable	22-11-30	MT
Transcript : Vimta Labs Limited, Q2 2023 Earnings Call, Oct 28, 2022	22-10-28
Vimta Labs Logs Rise in Fiscal Q2 Consolidated Profit	22-10-27	MT
Vimta Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-27	CI
Vimta Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-25	CI
Vimta Labs Limited Approves Dividend for the Financial Year Ended March 31, 2022, Payable on June 30, 2022	22-06-25	CI
Vimta Labs Limited Recommends Dividend for the Financial Year Ended March 31, 2022	22-05-30	CI
Transcript : Vimta Labs Limited, Q4 2022 Earnings Call, May 13, 2022	22-05-13
Vimta Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-12	CI
Vimta Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-12	CI

Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.

Sector

Biotechnology & Medical Research

Calendar

2024-05-17 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
VIMTA LABS LIMITED	+23.51%	130M
EXACT SCIENCES CORPORATION	-29.78%	9.84B
GUARDANT HEALTH, INC.	-2.96%	3.15B
IOVANCE BIOTHERAPEUTICS, INC.	+28.23%	2.99B
BGI GENOMICS CO., LTD.	-14.73%	2.15B
VERACYTE, INC.	-15.05%	1.8B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+69.62%	1.49B
CAREDX, INC	+23.08%	770M
SEEGENE, INC.	-2.84%	762M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-24.08%	575M

Bio Diagnostics & Testing